Swee Guan Teo, MBBS, MD

Safety and Feasibility of X-Sizer-Facilitated Rescue Percutaneous Coronary Intervention: A Preliminary Experience

08/01/2008

Although primary percutaneous coronary intervention (PCI) has been proven to be superior to thrombolytic therapy for the treatment of acute ST-elevation myocardial infarction (STEMI),1–3 the latter approach is still widely practiced due to...

Although primary percutaneous...

08/01/2008

Journal of Invasive Cardiology

Impact of Glycemic Control on Occurrence of No-Reflow and 30-Day Outcomes in Diabetic Patients Undergoing Primary Angioplasty fo

08/01/2008

Swee Guan Teo , MBBS, MD;

Antono Sutandar , MD;

Yean-Teng Lim , MBBS, MD;

Eric Hong , MBBS;

Hwee Bee Wong , MSc, MD;

Adrian F. Low , MD, MBBS;

Chi-Hang Lee , MD, MBBS, MRCP;

Huay-Cheem Tan , MBBS, MD;

Primary percutaneous transluminal coronary angioplasty (PTCA) has been consistently demonstrated to be superior to thrombolytic therapy and is currently the recommended therapy for myocardial infarction (MI).1 However, no-reflow phenomenon...

Primary percutaneous...

08/01/2008

Journal of Invasive Cardiology

Procedural Success and 30-Day Outcomes between CYPHER‚Ñ¢ and TAXUS¬Æ Stent Implantation for the Treatment of Bifurcation Lesions ‚Äî

08/01/2008

Chi-Hang Lee , MD, MBBS, MRCP;

Huay-Cheem Tan , MBBS, MD;

Swee Guan Teo , MBBS, MD;

Yean-Teng Lim , MBBS, MD;

Hwee Bee Wong , MSc, MD;

Jun Jie Zhang , MD;

Chao Yang Soon , MD;

Adrian F. Low , MD, MBBS;

CYPHER™ (sirolimus-eluting stent, Cordis, Johnson and Johnson, Miami, Florida) and TAXUS® (polymer-based paclitaxel-eluting stent, Boston Scientific Corporation, Natick, Massachusetts) stents are the two drug-eluting stents (DES) currently...

CYPHER™ (sirolimus-eluting...

08/01/2008

Journal of Invasive Cardiology